Skip to main content

Table 2 Percentage of grade 3 and above adverse events

From: FLT3 inhibitors in acute myeloid leukaemia: assessment of clinical effectiveness, adverse events and future research—a systematic review and meta-analysis

  1. Colour code: blue = 0 to 25%, purple = 26 to 50%, orange = 51 to 75% and red = 76 to 100%
  2. Abbreviations: cont control, gilt gilteritinib, lest lestaurtinib, mido midostaurin, quiz quizartinib, sora sorafenib
  3. *Includes patients from both AML15 and AML17 lestaurtinib trials following course 2 induction therapy
Back to article page

Systematic Reviews

ISSN: 2046-4053